Klaimee and the Emerging Shape of Agent Insurance

A company selling an autonomous agent into an enterprise has to answer two questions at once: why should the buyer trust the system, and who absorbs the loss if it causes harm? Klaimee's answer is unusually direct. Evaluate the deployed agent, issue a certification package, attach a financial commitment, and turn the result into documentation the buyer's legal and procurement teams can use.

That combination matters even before there is enough public information to judge the depth of the risk transfer. It makes the agent deployment—not AI in the abstract—the object being assessed, and it connects technical evidence to a commercial decision.

Klaimee is a San Francisco company in Y Combinator's Spring 2026 batch. Its public materials describe a certification, guarantee, and insurance offer for companies that build or deploy autonomous AI agents.

The disclosed evaluation combines a public-data scan, a governance assessment, and behavioural testing. Klaimee says it uses more than 100 probes and scores agents from A to F across eight dimensions, including scope violation, data exfiltration, unauthorised action, output integrity, adversarial manipulation, behavioural stability, model drift, and operational control.

Its certification package includes a risk score, findings, remediation recommendations, a badge, procurement documentation, and a financial guarantee. Klaimee also says certified agents can become eligible for AI liability insurance priced in part from the certification score. Its stated focus is bounded, non-safety-critical B2B use cases, with both third-party liability and some first-party loss scenarios described on its site.

A representative flow implied by Klaimee's public materials is straightforward:

1. An AI company describes the agent, its purpose, tools, permissions, and operating context.
2. Klaimee combines public-data review, governance questions, and adversarial behavioural testing.
3. The company receives a score, findings, remediation recommendations, certification documentation, and a financial guarantee; eligible coverage is presented as a further risk-transfer layer.
4. The vendor sends the package to the enterprise buyer's legal, procurement, or risk team to answer the question: who pays if the agent causes damage?
5. The deployment continues to change, with Klaimee also describing an adversarial testing playground for use after certification.

The product is therefore not only an underwriting instrument. It is a procurement unlock: a way to turn technical review and financial assurance into a document that can move a commercial relationship forward.

Klaimee's sharpest product decision is not the label “AI insurance.” It is packaging technical review and financial assurance around the individual deployed agent.

Enterprise buyers already ask vendors about model governance, security, data use, contractual liability, indemnity, and insurance. Agentic systems add a more specific problem: the software may hold credentials, write to production systems, communicate externally, or make decisions without transaction-by-transaction approval. A general certificate of insurance says little about those permissions. A model benchmark says little about who pays.

Klaimee joins the two. The evaluation gives the buyer a named review process; the guarantee gives the vendor a concrete response to the counterparty question; and the insurance proposition creates a path from assessment to risk transfer. In the near term, that interface may be as commercially important as the ultimate breadth of coverage.

Klaimee's public materials make several parts of the offer visible:

• the public-data, governance, and adversarial-testing methodology;
• the eight stated scoring dimensions and the certification package;
• the stated focus on bounded, non-safety-critical B2B use cases;
• the guarantee, insurance, and ongoing testing propositions.

Public materials reviewed by Clara on July 23, 2026 did not identify the guarantor or carrier, limits, forms, trigger language, exclusions, covered territories, claims process, or how the guarantee and insurance interact. They also do not yet explain how material changes to an agent affect eligibility. This opacity is normal for an early specialty product, but it leaves the depth and continuity of the financial commitment unresolved.

Klaimee argues that cyber and technology errors and omissions policies leave autonomous agent behaviour uncovered or ambiguous. That is a useful problem statement, but it should not be repeated as a universal coverage conclusion.

The practical gap can arise for specific reasons. Cyber insurance often centres on an external threat actor, unauthorised access, network security failure, or a defined privacy event. An agent may use legitimate credentials, operate within its granted permissions, and still make a damaging payment, commitment, disclosure, or system change. There may be no breach or unauthorised access in the traditional sense.

Technology E&O often centres on a software defect, professional service failure, or human negligence. An autonomous agent can produce harm through a chain of micro-decisions in which no single human error cleanly maps to the loss. Connected agents, delegated sub-agents, and abstraction layers can make the causal chain harder to assign even when the company remains legally accountable.

Those are recurring reasons a gap may arise, not a conclusion that a particular policy will not respond. A loss involving an agent could engage cyber, technology E&O, crime, general liability, media, or management liability. Whether any policy responds depends on the insured's role, the alleged harm, the causal chain, insuring agreements, definitions, endorsements, exclusions, representations, and applicable law.

The market is changing. Verisk says it has filed optional multistate generative-AI exclusion endorsements for its General Liability programme. That is evidence that insurers are creating new underwriting tools, not evidence that an exclusion is universal, mandatory, or already present across cyber and professional liability portfolios.

Klaimee is not relying only on a one-time questionnaire. Its behavioural testing examines the system directly, and customers receive access to an adversarial testing playground they can use after deployment. That is materially stronger than treating “uses AI” as a static application field.

The unresolved question is how the evaluated system remains connected to the live risk. Agents change. A company can swap models, alter prompts, add tools, raise transaction limits, expand credentials, change approval rules, reach new customers, or delegate to sub-agents. Each change can alter maximum plausible loss without changing the product name.

The problem becomes harder in an agent swarm. One agent may discover an opportunity, another negotiate, another change code, another move money, and another report success against a metric that never captured the underlying obligation. The abstraction layer can hide the relationship between a local decision and the aggregate position. A test of one agent is not automatically a test of the system it can recruit.

Public information does not yet explain which changes require re-evaluation, how a material change is detected, whether customers must report it, or what happens to the guarantee or insurance while the system is being re-certified. The strategic problem is therefore not merely test quality. It is maintaining identity between the evaluated agent, the deployed agent, and the agent to which the financial commitment applies.

Clara's existing research separates two levels of context. PASSPORT.md is agent-specific: it describes identity, sponsor, capabilities, permissions, attestations, and evidence for an individual agent or agent system. RISK.md is company-level: a reusable context packet for operations, exposures, controls, incidents, and material changes so the same facts do not have to be reconstructed for every market or renewal.

The Tail Risk Static Insurance Can't See examines why annual or point-in-time policies struggle when models, tools, permissions, and goals can change at machine speed. The three artifacts are complementary: PASSPORT.md identifies the agent and its authority, RISK.md supplies the broader company context, and the continuity research asks how both remain current.

Klaimee demonstrates a plausible first commercial layer: evaluation, certification, financial assurance, and procurement documentation. A durable underwriting system will also need evidence that survives change. At minimum:

• a stable inventory of the agent, its sponsor, purpose, models, tools, credentials, data, and operating environment;
• explicit records of what it may decide, spend, promise, publish, change, or execute;
• version and change history tied to materiality thresholds for review or re-underwriting;
• control evidence linked to the authority it constrains, including approvals, monitoring, escalation, shutdown, and rollback;
• incident, near-miss, claims, and remediation data that can improve both testing and underwriting over time.

This does not require insurance to become a real-time smart contract. The policy may remain annual. The evidence beneath it can still refresh when the risk changes materially.

Clara's near-term path is operational. First, work with agent-native companies as a specialist risk practice. Place the strongest available conventional coverage. Identify gaps with precision. Build evaluation and documentation practices around the company's actual deployed authority.

Then accumulate structured evidence: how companies change models, tools, credentials, limits, and delegation; which controls constrain loss; where incidents and near misses begin; and which facts change a founder's, buyer's, broker's, or underwriter's decision. That is the practice → research → insure loop in concrete form.

Over time, the evidence may support better submissions, clearer coverage, new wording, a programme, or another risk-transfer structure developed with a regulated market partner. The goal is not to issue the first certificate. It is to learn which evidence, controls, wording, and financial structure make the promise credible after the agent changes and after a loss occurs.

This is an independent research note based on public information. Clara has no disclosed commercial relationship with Klaimee and has not reviewed its guarantee, policy wording, underwriting files, customer contracts, or claims materials. Product and coverage statements attributed to Klaimee are Klaimee's claims, not Clara's verification of coverage. This note is not insurance or legal advice.

• Klaimee: product and FAQ
• Y Combinator: Klaimee company profile and launch
• Verisk: General Liability Hub
• Clara: The Tail Risk Static Insurance Can't See
• Clara: RISK.md: A Shared Language for Underwriting
• Clara: PASSPORT.md: Foundational Identity for Autonomous Economic Actors